Eventide Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-320,000
| Closed | -$5.34M | – | 165 |
|
|
2023
Q3 | $5.34M | Hold |
320,000
| – | – | 0.1% | 134 |
|
|
2023
Q2 | $8.84M | Buy |
+320,000
| New | +$8.84M | 0.15% | 123 |
|
|
2018
Q1 | – | Sell |
-275,000
| Closed | -$5.72M | – | 148 |
|
|
2017
Q4 | $5.72M | Buy |
275,000
+150,000
| +120% | +$3.12M | 0.3% | 80 |
|
|
2017
Q3 | $2.21M | Hold |
125,000
| – | – | 0.13% | 100 |
|
|
2017
Q2 | $1.41M | Buy |
+125,000
| New | +$1.41M | 0.09% | 103 |
|